Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Spineway S.A. is a specialized medical technology company that develops, manufactures, and distributes spinal implants and surgical instruments. The company's primary focus is on providing innovative solutions for spine surgery, aiming to improve procedural outcomes and patient well-being. Spineway S.A. operates globally, delivering products that cater to various spinal conditions, including scoliosis, degenerative disc disease, and trauma. With a comprehensive range of offerings, Spineway S.A. solutions are utilized by healthcare professionals in hospitals, clinics, and specialized surgical centers. Founded with a commitment to advancing spinal health, the company plays a significant role in the healthcare sector's niche market, continuously seeking to enhance surgical techniques and outcomes through its technologically advanced products.
The business is unprofitable at the operating level (-12.94% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 4.0%, steady but not accelerating. Margins contracted 5.5pp, which offsets some of the top-line progress.
ROIC dropped from -2.93% to -5.02%, capital efficiency is deteriorating. Negative free cash flow of -€163K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
€12M
▲ +4.0% YoY
Net Income (TTM)
-€2M
▲ +42.1% YoY
Op. Margin
-12.94%
▼ -5.5pp YoY
ROIC
-5.02%
▼ -2.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€163K
▲ +95.0% YoY
Op. Cash Flow (TTM)
-€163K
▲ +95.0% YoY
Net Debt
-€2M
Net Cash Position
Cash & Equiv.
€3M
3Y CAGR: +18.7%
Continue Research